Pradžia › Kartotinė mieloma › Ajova
Kartotinė mieloma klinikiniai tyrimai Ajova
17 tyrimai dėl Kartotinė mieloma ieško dalyvių vietose Ajova.
Miestai Ajova
Oficialus tyrimo tekstas (anglų kalba)
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- University of Iowa Hospitals and Clinics, Iowa City
- Mission Cancer Blood University of Iowa Health Care, Waukee
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07518186A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
- Research Site, Iowa City
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07073547A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- University of Iowa Hospital and Clinics, Iowa City
- Mission Cancer Blood, Waukee
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07258511A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- University of Iowa Health Care, Waukee
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT05552222Collection of Tissue Samples for Cancer Research
- University of Iowa, Iowa City
Renkami dalyviaiStebimasis tyrimas
2 Months · Visoms lytims · Atnaujinta 2026-09-16 · NCT00900198Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- University of Iowa, Iowa City
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT06297226Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- ir dar 18
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT04566328AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
- Research Site, Iowa City
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT05850234Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Research Site, Iowa City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT07764978A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- University of Iowa, Iowa City
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT07284758Integrated Cancer Repository for Cancer Research
- Methodist Jennie Edmundson Hospital, Council Bluffs
- Covenant Medical Center, Inc, Waterloo
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 19 iki 110 · Visoms lytims · Atnaujinta 2026-06-29 · NCT02012699Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Mission Cancer and Blood - Ankeny, Ankeny
- University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
- Physicians' Clinic of Iowa PC, Cedar Rapids
- ir dar 7
Renkami dalyviai3 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-06-10 · NCT05561387Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
- University of Iowa, Iowa City
Renkami dalyviai2 fazė
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2026-06-04 · NCT06974786Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
- University of Iowa Health Care, Iowa City
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-04 · NCT07581704Sleep Apnea in Patients With MGUS and MM
- University of Iowa, Iowa City
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2025-11-10 · NCT04114084Activity Levels in Bone Marrow Transplant Patients
- University of Iowa, Iowa City
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2025-11-10 · NCT04115241Limited-duration Teclistamab
- University of Iowa Hospitals and Clinics, Iowa City
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-01 · NCT05932680Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.